Objectives: Multidrug efflux pumps are proteins known to play an important role in resistance in bacteria. These proteins are located in the inner membrane (IM), together with many other proteins, including inducible permeases that participate in the uptake of non-phosphotransferase system (PTS) carbohydrates (i.e. carbohydrates uptaken by mechanisms other than the PTS). However, lipid bilayer space in the IM is limited. Therefore, we examined whether the overexpression of unrelated IM proteins is able to interfere with the efflux-mediated resistance mechanism, consequently increasing the susceptibility towards different antimicrobial compounds.
Introduction
Bacteria are recognized as the aetiological agents of many important infectious diseases in humans, resulting in death and economic loss. 1 The introduction of antibiotic therapy in 1940 strongly contributed to saving the lives of millions of people. Nevertheless, the problem of antimicrobial drug-resistant pathogens was recognized shortly after antimicrobial drugs began to be used. In fact, it is not uncommon to observe the emergence of antibiotic resistance in bacteria when they encounter a new, commercially produced antibiotic. 2 -5 Over the years, the selective pressure exerted by different new antibiotics has resulted in bacteria bearing different kinds of resistance mechanisms, leading to the multidrug resistant (MDR) phenotype. 3 The appearance of MDR is one of the most important concerns in the clinical and public-health management of nearly every type of infectious disease. 1, 6, 7 Some authors have defined the MDR phenotype as resistance to two or more antibiotic classes. 3, 8 Bacteria exhibit different strategies to develop resistance to antibiotics, 9 -11 and prevention of antibiotic accumulation in the bacterial cytoplasm (either by decreasing influx or, most importantly, by increasing efflux) has been considered a major contributor to the emergence of MDR pathogens. 3,12 -17 Antibiotic efflux is efficiently achieved by efflux pumps-proteins located in the inner membrane of Gram-negative bacteria, and in the cytoplasmic membrane of Gram-positive bacteria. 15 These pumps have been described as promiscuous/polyselective proteins, able to recognize and expel a large variety of antimicrobial agents, including antibiotics, biocides and detergents, thereby yielding their role in the development of the MDR phenotype. 12, 13, 15, 17 It has been reported that the protein content in the bacterial inner membrane is diverse, including the efflux pumps and more than 100 other different types of proteins. 18 Moreover, in Gramnegative bacteria 20% -30% of total protein is located at the inner membrane, whereas only 2% are outer membrane proteins. 19, 20 Nevertheless, the membrane lipid bilayer occupies less than 4% of total bacterial volume, strongly suggesting that the available space for the overproduction of inner membrane proteins is limited. 21 Accordingly, many inner membrane proteins, including several efflux pumps, are especially difficult to overproduce in vivo, 22 and are tightly regulated in order to prevent excessive production. 23, 24 Besides the efflux pumps, the inner membrane also harbours other proteins, including transporters/permeases for the uptake of solutes, including carbohydrates. 24 -33 In Salmonella, Escherichia coli and other enterobacteria, the phosphotransferase system (PTS), also located in the inner membrane, performs the translocation of glucose with concomitant phosphorylation. 21, 25 When bacteria grow under glucose-depleted conditions, other inner membrane permeases, normally repressed by catabolite repression, are expressed in order to take up alternative carbon sources. 24 -33 Given that the inner membrane space is limited, it is plausible that overproduction of carbohydrate permeases due to the presence of a non-PTS carbohydrate as the sole carbon source (or the overproduction of any inner-membrane protein) might alter the protein composition of the inner membrane, thereby affecting efflux-pump-mediated antibiotic resistance.
In this paper it is demonstrated that efflux-pump-mediated antibiotic resistance can be subverted by culturing bacteria with non-PTS sugars as the sole carbon source, or by artificially overproducing unrelated inner-membrane proteins.
Materials and methods

Bacterial strains, media and growth conditions
A total of 60 clinical strains, including Pseudomonas aeruginosa (50 clinical strains) and Acinetobacter baumannii (10 clinical strains), which had been collected at the Hospital of Pontificia Universidad Cató lica de Chile and from other healthcare facilities throughout the country, were used for antimicrobial-susceptibility determination. The Salmonella enterica serotype Typhimurium strains used in this study are derivatives of the parental wild-type strains ATCC 14028s or LT2.
Salmonella Typhimurium ATCC 14028s DsmvA::cat 34 and Salmonella Typhimurium LT2/F ′ ::T-POP (MST4208) were kindly provided by Carlos Santiviago (Universidad de Chile, Santiago, Chile) and Stanley Maloy (San Diego State University, San Diego, USA), respectively. Salmonella Typhimurium LT2 DxylE::aph/F ′ ::T-POP was constructed using MST4208 as the parental strain and the lambda red recombination system. 35 The primers used in the lambda red recombination system were xylE(H1+P1) (GGGGCGGCGATGAGTGAATCGTTCATGATCTTCTCCCTTTTGTA GGCTGGAGCTGCTTCG) and xylE(H2+P2) (CACATAACGAGAAATAAAGACATA G CAGACCAAATTAAAGCATATGAATATCCTCCTTAG). 
PCR amplifications and plasmid construction
PCR amplifications were performed using an Eppendorf thermal cycler and Taq DNA polymerase (Fermentas). Reaction mixtures (50mL) contained 1× PCR buffer, 1.5 mM MgCl 2 , dNTPs (200 mM each), primers (1 mM each), 100 ng of template DNA and 2 U of polymerase. Standard conditions for amplification were 30 cycles at 968C for 40 s, 558C for 45 s and 728C for 2 min, followed by a final extension step at 728C for 10 min. Template Salmonella Typhimurium LT2/F ′ ::T-POP (MST4208) chromosomal DNA was prepared as previously described. 36 The pTET R plasmid was constructed by cloning the T-POP transposon 37 into plasmid pCR-TOPO 2.1 TA using a cloning kit (Invitrogen) according to the manufacturer's instructions. Primers used were P1T-POPf (AATCAT-TAAGTTAAGGTGGA) and P2T-POPr (TATCAAAATCATTAAGGTTA). Products generated by PCR amplification were resolved in 0.8% agarose gels.
Antimicrobial susceptibility tests
The disc diffusion assay we used to determine antibiotic susceptibility to different antibiotics or toxic compounds was a modification of a standard method described previously. 38 Overnight cultures of tested strains were grown in LB medium. Then, bacteria were washed three times and resuspended in PBS. Aliquots ( 10 6 cells) were spread on M9 plates (6 mg/mL NaH 2 PO 4 , 3 mg/mL K 2 HPO 4 , 1 mg/mL NH 4 Cl, 0.5 mg/mL NaCl, 0.12 mg/mL MgSO 4 and 0.015 mg/mL CaCl 2 ) supplemented with different sugars (2 mg/mL glucose, 2 mg/mL galactose, 2 mg/mL arabinose or 2 mg/mL xylose) and allowed to dry. Sterile filter paper discs were spotted with 10 mL of different antimicrobial compounds (50 mg/L kanamycin, 100 mg/L ampicillin, 50 mg/L gentamicin, 10 mg/L streptomycin, 10 mg/L tetracycline, 20 mg/L chloramphenicol, 0.01 mg/L meropenem, 25 mg/L acriflavine, 50 mg/L benzalkonium chloride, 1 mM paraquat or 10 mM benzyl viologen). The discs were placed in the centre of the plates, and incubated overnight at 378C. To determine the antibiotic susceptibility to different antimicrobial agents independent of the carbon source, Mueller-Hinton agar (300 g/L beef infusion, 15.5 g/L casein acid hydrolysate, 1.5 g/L starch and 17 g/L agar) was used instead of M9 minimal medium. When required, the medium was supplemented with 10 mg/L tetracycline or 12.5 mM carbonyl cyanide-m-chlorophenylhydrazone (CCCP). The diameters of the zones of growth inhibition were calculated as the average of two measurements along two axes passing through the centre of the disc. In all cases, diameters differed by no more than 1 mm.
Results and discussion
Carbon source alters the efflux-pump-mediated antimicrobial resistance in Salmonella Typhimurium We hypothesized that it is possible to alter the efflux-pumpmediated antibiotic resistance by overproducing unrelated inner membrane proteins, such as carbohydrate permeases. An easy way to increase the production of permeases is to culture bacteria with a non-PTS carbohydrate as the sole carbon source. 24 -33 In order to assess the effect of a carbon source on efflux-pump-mediated resistance, we challenged Salmonella Typhimurium with N,N ′ -dimethyl-4,4 ′ -bipyridinium dichloride (methyl viologen dichloride, or 'paraquat') in a disc diffusion assay, using M9 minimal medium supplemented with glucose Villagra et al.
(6C) or with non-PTS carbohydrates such as galactose (6C), arabinose (5C) or xylose (5C). It has been reported that the slight resistance in Salmonella Typhimurium to paraquat and other quaternary ammonium compounds, such as acriflavine, is achieved by expelling the drug mainly through the SmvA efflux pump. 34, 39 As reported in Table 1 , Salmonella Typhimurium exhibited increased susceptibility to paraquat when a non-PTS carbohydrate was the sole carbon source, suggesting that the overproduction of permeases such as GalP, AraE or XylE, due to the presence of an non-PTS sugar, 27, 30, 31, 36 was interfering with the efflux pumps associated with resistance to paraquat. If this hypothesis is correct, the effect of the carbon source on the resistance to paraquat should be lower in Salmonella Typhimurium DsmvA compared with wild-type. According to our reasoning, the growth inhibition halos in the presence of paraquat would be similar for all the carbon sources used when the DsmvA mutant is tested; indeed, there was only a slight increase with the non-PTS carbon sources (Table 1 ). This could be explained by the presence of alternative efflux pumps that are able to expel paraquat, such as YddG. 34 To determine the effect of the carbon source on effluxmediated resistance in an independent way, we tested the Salmonella Typhimurium tetracycline resistance. This serovar is considered to be susceptible to tetracycline, as shown in Table 2 . Moreover, the carbon source seems to have no effect in the susceptibility to this antibiotic (Table 2) . In order to test whether the carbon source is able to alter the efflux-mediated resistance to tetracycline, we tested Salmonella Typhimurium LT2/F ′ ::T-POP (MST4208), a strain that harbours one copy of the T-POP element. 40 T-POP carries the tetR (transcriptional repressor) and tetA (tetracycline efflux pump) genes. Tetracycline inhibits TetR repression, thereby allowing production of the TetA efflux pump. 40 As shown in Table 2 , the efflux-mediated resistance to tetracycline exhibited by the MST4208 strain can be subverted by the use of a non-PTS carbohydrate as the sole carbon source, confirming our previous observation. Moreover, it is possible to circumvent the effect achieved with xylose by adding glucose to the culture medium (Table 2) , strongly suggesting that the mechanism responsible for decreasing the resistance to tetracycline in this case responded to catabolite repression. It has been reported that the XylE permease is induced when xylose is present in the culture medium, and that it responds to catabolite repression in Salmonella Typhimurium. 31 To assess the contribution of the inner membrane protein XylE to decreasing tetracycline resistance, we constructed the strain Salmonella Typhimurium LT2 DxylE::aph/F ′ ::T-POP, derived from MST4208, to test its resistance to tetracycline in M9 medium with glucose, xylose, or a mixture of glucose and xylose as carbon source. As shown in Table 2 , resistance to tetracycline was not influenced by carbon source (i.e. glucose or xylose) in the DxylE strain, supporting the belief that decreased efflux-mediated resistance depends on the presence of xylE, under the tested conditions. The susceptibility of these strains to kanamycin, gentamicin or streptomycin was not increased when cultured with non-PTS carbohydrates (data not shown), suggesting that the effects shown in Table 1 and 2 are only achieved when efflux pumps are involved.
Taken together, these results demonstrate that the carbon source alters the efflux-mediated antimicrobial resistance in Salmonella Typhimurium, presumably because of the overexpression of carbohydrate permeases that interfere with efflux pumps. Relative to the inhibition halo measured in the M9 medium supplemented with glucose. Relative to the inhibition halo measured in the M9 medium supplemented with glucose.
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Overexpression of an unrelated inner membrane protein decreases efflux-mediated resistance to toxic compounds in Salmonella Typhimurium
We assessed whether overexpressing unrelated inner membrane proteins increases efflux-mediated susceptibility regardless of the carbon source. Therefore, we challenged Salmonella Typhimurium ATCC 14028s/pTET R with different antimicrobial compounds in presence or in absence of tetracycline. This strain harbours the T-POP element cloned into the high copy number plasmid pCR-TOPO TA 2.1 TM . Thus, the presence of tetracycline in the culture medium strongly increases the production of the inner-membrane tetracyclinespecific pump TetA. 37 If our hypothesis is correct, overproduction of TetA interferes with other efflux pumps, thereby increasing the susceptibility to toxic compounds other than tetracycline, normally expelled by efflux pumps. A lawn of Salmonella Typhimurium was seeded in Mueller -Hinton plates with or without tetracycline. Then, we put paper discs impregnated with different toxic compounds normally expelled by efflux pumps in Salmonella Typhimurium, in the centre of the plate. These compounds included acriflavine (expelled by SmvA 39 and AcrB 41, 42 ), benzalkonium chloride (expelled AcrB 41, 42 ) or benzyl viologen (expelled by SmvA 43, 44 and YddG 44 ). The resistance to ampicillin and kanamycin, encoded in the pCR-TOPO TA 2.1 TM vector by the bla (b-lactamase) and aph (aminoglycoside phosphotransferase) genes respectively, is unrelated to efflux pumps. Thus, we included these antibiotics as a control. As shown in Table 3 , Salmonella Typhimurium ATCC 14028s/pTET R resistance to acriflavine, benzalkonium chloride and benzyl viologen was decreased when tetracycline was added to the plates, compared with the same strain in the plates with the non-tetracycline control, strongly suggesting that the high production of the innermembrane protein TetA was interfering with efflux-mediated resistance to the tested antimicrobial compounds. In contrast, the presence of tetracycline produced no effect on the resistance to ampicillin or kanamycin, supporting the hypothesis that overexpression of unrelated inner-membrane proteins interferes with antimicrobial resistance only when effluxmediated mechanisms are involved.
All these results together show that it is possible to decrease efflux-mediated resistance to different toxic compounds by overexpressing an unrelated inner membrane protein.
Culturing clinically important Gram-negative bacteria with non-PTS carbohydrates as a sole carbon source decreases the efflux-mediated resistance towards toxic compounds We determined whether it is possible to decrease effluxmediated resistance by culturing clinically important Gramnegative strains other than Salmonella Typhimurium in non-PTS carbohydrates as the sole carbon source. We tested P. aeruginosa and A. baumannii since it is believed that the presence of xylose stimulates the synthesis of dedicated inner-membrane permeases. 45 These two clinical strains are considered to be the most important pathogens of nosocomial infections, particularly in intensive care units. Moreover, they mainly infect immunocompromised patients, affecting lungs, urinary tract, eyes, skin burns and soft tissue. 46, 47 In addition, P. aeruginosa and A. baumannii constitute a major public health problem due to their propensity to develop resistance to several drugs, and isolates exhibiting multidrug resistance are emerging in clinical settings. 47, 48 The resistance mechanisms presented by these bacteria include the production of b-lactamases, target-site or outer-membrane modifications and, more importantly, the efflux pumps. 47, 48 To determine whether it is possible to decrease the efflux-mediated resistance of these bacteria, we performed disc diffusion assays using M9 medium supplemented with glucose or xylose. In the case of P. aeruginosa, we tested the resistance to meropenem (0.01 mg/L), an antibiotic commonly used to treat infections by these bacteria. 49, 50 Meropenem resistance in P. aeruginosa is achieved mainly by three mechanisms: efflux pumps (MexAB/OprM), carbapenemases and mutations in the porin oprD gene. 49, 51 In the case of A. baumannii, we tested tetracycline and chloramphenicol resistance, which is normally achieved by efflux pumps. 51 In order to distinguish between efflux-mediated and efflux-independent resistance mechanisms, experiments were performed to detect synergy between meropenem, tetracycline or chloramphenicol, with the Villagra et al.
efflux pump inhibitor CCCP added to the M9 plate, as previously described. 52 Synergy between the tested antibiotic and CCCP indicates that efflux pump activity contributes to this resistance. 52 Using this procedure, we tested the meropenem resistance of 50 clinical strains of P. aeruginosa under different conditions. We found three different resistance patterns as shown in Table 4 : (i) P. aeruginosa 1, considered to be susceptible to meropenem, presented no difference whether cultured in M9/ glucose or M9/xylose. Accordingly, no synergy was found when CCCP was added, strongly suggesting that efflux systems are not involved in this case. This result is comparable to that shown in Table 2 with Salmonella Typhimurium WT, where the carbon source did not affect the tetracycline resistance because that strain lacks the TetA pump. We found only 1 P. aeruginosa clinical strain presenting this kind of meropenem resistance pattern. (ii) P. aeruginosa 2, considered to be resistant to meropenem, presented decreased resistance to this antibiotic when cultured in M9/xylose compared with M9/glucose. Consistently, the presence of CCCP decreased meropenem resistance, demonstrating that an efflux pump is involved in this case. We found 13 P. aeruginosa clinical strains presenting similar a resistance pattern (Table 4 ). (iii) P. aeruginosa 3, also considered to be resistant to meropenem, presented the same behaviour in all the media tested (Table 4) . These results suggest that the P. aeruginosa 3 strain presents meropenem resistance through effluxindependent mechanisms. We found 36 P. aeruginosa clinical strains presenting this resistance pattern (Table 4 ). In the case of A. baumannii, we also found a perfect correlation between the increase in susceptibility found with CCCP and xylose ( Table 4) .
All these results together strongly suggest that overexpression of inner membrane proteins by using a non-PTS carbohydrate as the sole carbon source, or by artificially introducing a high number of copies of an unrelated efflux-pump gene, is competing with the antibiotic efflux systems, thereby decreasing the efflux-mediated resistance to different antimicrobial compounds in Salmonella Typhimurium. This competition arises because of the limited available space in the bacterial inner membrane, 19 -21 or by an unknown mechanism. In the case of P. aeruginosa and A. baumannii, we observed decreased efflux-mediated resistance towards different antimicrobial compounds when cultured with xylose as the sole carbon source. It has been shown that both Gram-negative and Gram-positive bacteria possess inducible permeases dedicated to xylose transport. 31,53 -55 Thus, it is plausible that the decreased efflux-mediated resistance when xylose was used as the sole carbon source in P. aeruginosa and A. baumannii could be achieved by overexpression of inner membrane permeases. The data presented here suggest that an alternative method, besides the use of CCCP, 52 can elicit the participation of efflux systems in a given resistance response in Salmonella Typhimurium-and in P. aeruginosa and A. baumannii. This method involves the detection of synergy between the tested antimicrobial compound and xylose (or another non-PTS carbohydrate) when used as the sole carbon source, since in this work we showed a perfect correlation between this procedure and the classical method with CCCP. Therefore, this work could serve as starting point for the development of a new treatment against infections, for instance combining antibiotics with xylose when used in topical compositions. Since the MDR phenotype is mainly associated with the presence of efflux-mediated systems, a method that aims to interfere with the efflux pumps could be an invaluable tool in the fight against antibiotic-resistant pathogens. 
